SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Diane Leadman who wrote (115)9/17/1997 9:16:00 AM
From: Joel Oseran   of 1510
 
Also,

I think the bio-tech sector in general is percieved more favourably by investors these days.

Because of no material news on IMNR......I would surmise clinical testing is proceeding favourably and for us small-time investors its the old phrase "buy on rumour".

I dont know. All I do know is that IMNR has very promising drugs in different categories not dependant on one success or failure.

jOel:-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext